产前雄激素编程成人代谢综合征的性别差异
研究纳入274名母亲参与 Collaborative Perinatal Project 新英格兰出生队列的子代,在其39至50岁时评估代谢综合征。孕晚期母亲血清雄激素生物活性最高四分位组子代代谢综合征风险升高,此关联在女性中显著但男性不显著,女性子代高血压风险也升高。
要点
- 孕晚期母亲雄激素生物活性最高四分位组子代代谢综合征风险升高。
- 该关联在女性子代中显著,男性子代中不显著。
- 女性子代高血压风险也随母亲雄激素水平升高而增加。
核心结论
- 母亲雄激素水平较高与成人子代代谢综合征风险增加相关,该效应在女性中显著但男性不显著。
研究设计与样本
- 研究为队列研究,纳入 Collaborative Perinatal Project 新英格兰出生队列中274名母亲的成人子代,在39至50岁时评估。
- 孕晚期母亲血清雄激素生物活性采用受体介导的荧光素酶表达生物测定法测量。
主要发现
- 成人子代平均年龄44.7±2.6岁,平均体重指数29.7±6.7 kg/m2。
关键数值与推荐
- 代谢综合征采用成人治疗组III(ATP III)标准评估。
- 雄激素生物活性以四分位分析,最低四分位(Q1)为参照。
临床怎么用
- 提示临床关注母亲孕期雄激素水平对子代远期代谢风险的潜在影响,尤其是女性子代。
- 对于母亲孕期雄激素水平较高的女性子代,可考虑加强代谢综合征和血压监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Growing preclinical evidence suggests that hormonal programming by androgens in utero may contribute to cardiovascular disease risk in adult offspring. However, the effect of prenatal androgens on cardiometabolic outcomes in the human population, especially their potential differential impact on male vs female offspring, has not been well studied. DESIGN: Adult offspring (n = 274) of mothers enrolled in the New England birth cohorts of the Collaborative Perinatal Project were assessed at ages 39 to 50. Androgen bioactivity was measured in maternal serum during the third trimester using a receptor-mediated luciferase expression bioassay. Metabolic syndrome (MetS) using Adult Treatment Panel III criteria was assessed in adult offspring. Bioactive androgens were analyzed as quartiles, with the lowest quartile (Q1) defined as the reference. Generalized estimating equations were used to evaluate the relationship of maternal bioactive androgens on offspring MetS risk overall and by sex, controlling for potential confounders and intrafamilial correlation. RESULTS: Mean age and body mass index of adult offspring were 44.7 ± 2.6 years and 29.7 ± 6.7 kg/m2, respectively. Participants born to mothers with the highest quartile (Q4) compared with Q1 of bioactive androgens had higher risk for MetS [adjusted odds ratio (aOR): 2.53(1.07 to 6.02)]. Stratified by sex, this association was found to be significant among women [Q4 vs Q1; aOR: 4.06 (1.10 to 14.93)] but not men [Q4 vs Q1; aOR: 1.67 (0.53 to 5.26)]. Women born to mothers with the highest levels of maternal bioactive androgens also demonstrated a 4.84-fold increased odds for having hypertension [Q4 vs Q1; aOR: 4.84 (1.12 to 20.85)]. CONCLUSION: Higher levels of maternal androgens were associated with increased risk for incident MetS in adult offspring, an effect that was significant in women but not men.
引用
- Huang G, Cherkerzian S, Loucks EB, et al. Sex Differences in the Prenatal Programming of Adult Metabolic Syndrome by Maternal Androgens. J Clin Endocrinol Metab. 2018. PMID: 30113645. doi:10.1210/jc.2018-01243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。